Warning: mkdir(): No space left on device in /var/www/tg-me/post.php on line 37

Warning: file_put_contents(aCache/aDaily/post/EFECTOSADVERSOS1/-1839-1840-): Failed to open stream: No such file or directory in /var/www/tg-me/post.php on line 50
🌎EFECTOS ADVERSOS🛡💉 | Telegram Webview: EFECTOSADVERSOS1/1840 -
Telegram Group & Telegram Channel
Francine Boyer, de 54 años, desarrolló coágulos de sangre en el cerebro y falleció el 23 de abril de 2021, 14 días después de recibir la inyección C-19 de AstraZeneca que tomó el 9 de abril, sufrió dolores de cabeza debilitantes y fatiga extrema, fue trasladada a un hospital donde le diagnosticaron trombosis cerebral y posteriormente falleció.

Fuente: THE COVID BLOG

Recopilación de casos que han presentado efectos adversos o muertes posteriores a la "inyección".
https://www.tg-me.com/us/EFECTOS ADVERSOS/com.EFECTOSADVERSOS1



tg-me.com/EFECTOSADVERSOS1/1840
Create:
Last Update:

Francine Boyer, de 54 años, desarrolló coágulos de sangre en el cerebro y falleció el 23 de abril de 2021, 14 días después de recibir la inyección C-19 de AstraZeneca que tomó el 9 de abril, sufrió dolores de cabeza debilitantes y fatiga extrema, fue trasladada a un hospital donde le diagnosticaron trombosis cerebral y posteriormente falleció.

Fuente: THE COVID BLOG

Recopilación de casos que han presentado efectos adversos o muertes posteriores a la "inyección".
https://www.tg-me.com/us/EFECTOS ADVERSOS/com.EFECTOSADVERSOS1

BY 🌎EFECTOS ADVERSOS🛡💉





Share with your friend now:
tg-me.com/EFECTOSADVERSOS1/1840

View MORE
Open in Telegram


EFECTOS ADVERSOS Telegram | DID YOU KNOW?

Date: |

However, analysts are positive on the stock now. “We have seen a huge downside movement in the stock due to the central electricity regulatory commission’s (CERC) order that seems to be negative from 2014-15 onwards but we cannot take a linear negative view on the stock and further downside movement on the stock is unlikely. Currently stock is underpriced. Investors can bet on it for a longer horizon," said Vivek Gupta, director research at CapitalVia Global Research.

Should You Buy Bitcoin?

In general, many financial experts support their clients’ desire to buy cryptocurrency, but they don’t recommend it unless clients express interest. “The biggest concern for us is if someone wants to invest in crypto and the investment they choose doesn’t do well, and then all of a sudden they can’t send their kids to college,” says Ian Harvey, a certified financial planner (CFP) in New York City. “Then it wasn’t worth the risk.” The speculative nature of cryptocurrency leads some planners to recommend it for clients’ “side” investments. “Some call it a Vegas account,” says Scott Hammel, a CFP in Dallas. “Let’s keep this away from our real long-term perspective, make sure it doesn’t become too large a portion of your portfolio.” In a very real sense, Bitcoin is like a single stock, and advisors wouldn’t recommend putting a sizable part of your portfolio into any one company. At most, planners suggest putting no more than 1% to 10% into Bitcoin if you’re passionate about it. “If it was one stock, you would never allocate any significant portion of your portfolio to it,” Hammel says.

EFECTOS ADVERSOS from us


Telegram 🌎EFECTOS ADVERSOS🛡💉
FROM USA